Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Conserved DNA methylation combined with differential frontal cortex and cerebellar expression distinguishes C9orf72-associated and sporadic ALS, and implicates SERPINA1 in disease.

Ebbert MTW, Ross CA, Pregent LJ, Lank RJ, Zhang C, Katzman RB, Jansen-West K, Song Y, da Rocha EL, Palmucci C, Desaro P, Robertson AE, Caputo AM, Dickson DW, Boylan KB, Rademakers R, Ordog T, Li H, Belzil VV.

Acta Neuropathol. 2017 Nov;134(5):715-728. doi: 10.1007/s00401-017-1760-4. Epub 2017 Aug 14.

2.

Measuring Resilience in Two Generations: Psychometric Properties of Available Instruments.

Cohen MZ, Kupzyk KA, Holley LM, Katzman RM.

J Nurs Meas. 2017 Aug 1;25(2):332-352. doi: 10.1891/1061-3749.25.2.332.

PMID:
28789755
3.

ALS and FTD: an epigenetic perspective.

Belzil VV, Katzman RB, Petrucelli L.

Acta Neuropathol. 2016 Oct;132(4):487-502. doi: 10.1007/s00401-016-1587-4. Epub 2016 Jun 9. Review.

4.

Epithelial PIK3R1 (p85) and TP53 Regulate Survivin Expression during Adaptation to Ileocecal Resection.

Cohran V, Managlia E, Bradford EM, Goretsky T, Li T, Katzman RB, Cheresh P, Brown JB, Hawkins J, Liu SXL, De Plaen IG, Weitkamp JH, Helmrath M, Zhang Z, Barrett TA.

Am J Pathol. 2016 Jul;186(7):1837-1846. doi: 10.1016/j.ajpath.2016.03.008. Epub 2016 May 6.

5.

C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins.

Zhang YJ, Gendron TF, Grima JC, Sasaguri H, Jansen-West K, Xu YF, Katzman RB, Gass J, Murray ME, Shinohara M, Lin WL, Garrett A, Stankowski JN, Daughrity L, Tong J, Perkerson EA, Yue M, Chew J, Castanedes-Casey M, Kurti A, Wang ZS, Liesinger AM, Baker JD, Jiang J, Lagier-Tourenne C, Edbauer D, Cleveland DW, Rademakers R, Boylan KB, Bu G, Link CD, Dickey CA, Rothstein JD, Dickson DW, Fryer JD, Petrucelli L.

Nat Neurosci. 2016 May;19(5):668-677. doi: 10.1038/nn.4272. Epub 2016 Mar 21.

6.

Response to Yablonsky’s letter to the editor.

Cohen MZ, Holley LM, Wengel SP, Katzman RM.

West J Nurs Res. 2013 Oct;35(9):1225-7. No abstract available.

PMID:
24137789
7.

Antioxidant properties of mesalamine in colitis inhibit phosphoinositide 3-kinase signaling in progenitor cells.

Managlia E, Katzman RB, Brown JB, Barrett TA.

Inflamm Bowel Dis. 2013 Sep;19(10):2051-60. doi: 10.1097/MIB.0b013e318297d741.

PMID:
23867870
8.

p53 mediates TNF-induced epithelial cell apoptosis in IBD.

Goretsky T, Dirisina R, Sinh P, Mittal N, Managlia E, Williams DB, Posca D, Ryu H, Katzman RB, Barrett TA.

Am J Pathol. 2012 Oct;181(4):1306-15. doi: 10.1016/j.ajpath.2012.06.016. Epub 2012 Aug 3. Erratum in: Am J Pathol. 2013 Feb;182(2):610.

9.

Radiofrequency ablation for dysplasia in Barrett's esophagus restores β-catenin activation within esophageal progenitor cells.

Krishnan K, Komanduri S, Cluley J, Dirisina R, Sinh P, Ko JZ, Li L, Katzman RB, Barrett TA.

Dig Dis Sci. 2012 Feb;57(2):294-302. doi: 10.1007/s10620-011-1899-0. Epub 2011 Sep 24.

PMID:
21948356
10.

p53 and PUMA independently regulate apoptosis of intestinal epithelial cells in patients and mice with colitis.

Dirisina R, Katzman RB, Goretsky T, Managlia E, Mittal N, Williams DB, Qiu W, Yu J, Chandel NS, Zhang L, Barrett TA.

Gastroenterology. 2011 Sep;141(3):1036-45. doi: 10.1053/j.gastro.2011.05.032. Epub 2011 May 27.

11.

Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis.

Lee G, Goretsky T, Managlia E, Dirisina R, Singh AP, Brown JB, May R, Yang GY, Ragheb JW, Evers BM, Weber CR, Turner JR, He XC, Katzman RB, Li L, Barrett TA.

Gastroenterology. 2010 Sep;139(3):869-81, 881.e1-9. doi: 10.1053/j.gastro.2010.05.037. Epub 2010 May 24.

12.

Epithelial NF-kappaB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation.

Tang Y, Clayburgh DR, Mittal N, Goretsky T, Dirisina R, Zhang Z, Kron M, Ivancic D, Katzman RB, Grimm G, Lee G, Fryer J, Nusrat A, Turner JR, Barrett TA.

Am J Pathol. 2010 Jan;176(1):158-67. doi: 10.2353/ajpath.2010.090548. Epub 2009 Dec 11.

13.

The prevalence and malignancy of Alzheimer disease: a major killer.

Katzman R.

Alzheimers Dement. 2008 Nov;4(6):378-80. doi: 10.1016/j.jalz.2008.10.003. Epub 2008 Oct 22. No abstract available.

PMID:
18945645
14.

SV40 reporter viruses.

Katzman RB, Seeger M, Rundell K.

J Virol Methods. 2008 Jun;150(1-2):7-13. doi: 10.1016/j.jviromet.2008.02.013. Epub 2008 Apr 9.

15.

Role of SV40 ST antigen in the persistent infection of mesothelial cells.

Fahrbach KM, Katzman RB, Rundell K.

Virology. 2008 Jan 20;370(2):255-63. Epub 2007 Oct 23.

16.

The notch regulator MAML1 interacts with p53 and functions as a coactivator.

Zhao Y, Katzman RB, Delmolino LM, Bhat I, Zhang Y, Gurumurthy CB, Germaniuk-Kurowska A, Reddi HV, Solomon A, Zeng MS, Kung A, Ma H, Gao Q, Dimri G, Stanculescu A, Miele L, Wu L, Griffin JD, Wazer DE, Band H, Band V.

J Biol Chem. 2007 Apr 20;282(16):11969-81. Epub 2007 Feb 22.

17.

Commentary on "Diagnosis of Alzheimer's disease: two decades of progress".

Katzman R.

Alzheimers Dement. 2005 Oct;1(2):107-8. doi: 10.1016/j.jalz.2005.09.010. No abstract available.

PMID:
19595836
18.

Anosmia is very common in the Lewy body variant of Alzheimer's disease.

Olichney JM, Murphy C, Hofstetter CR, Foster K, Hansen LA, Thal LJ, Katzman R.

J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1342-7.

19.
20.
21.
22.

Cholesterol-dependent infection of Burkitt's lymphoma cell lines by Epstein-Barr virus.

Katzman RB, Longnecker R.

J Gen Virol. 2003 Nov;84(Pt 11):2987-92.

PMID:
14573803
23.

Neuropsychological deficits associated with Alzheimer's disease in the very-old: discrepancies in raw vs. standardized scores.

Bondi MW, Houston WS, Salmon DP, Corey-Bloom J, Katzman R, Thal LJ, Delis DC.

J Int Neuropsychol Soc. 2003 Jul;9(5):783-95.

24.

Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals.

Salmon DP, Thomas RG, Pay MM, Booth A, Hofstetter CR, Thal LJ, Katzman R.

Neurology. 2002 Oct 8;59(7):1022-8.

PMID:
12370456
25.

Characterization of the human alpha-synuclein gene: Genomic structure, transcription start site, promoter region and polymorphisms.

Xia Y, Saitoh T, Uéda K, Tanaka S, Chen X, Hashimoto M, Hsu L, Conrad C, Sundsmo M, Yoshimoto M, Thal L, Katzman R, Masliah E.

J Alzheimers Dis. 2001 Oct;3(5):485-494.

PMID:
12214035
26.

The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function.

Merchant M, Swart R, Katzman RB, Ikeda M, Ikeda A, Longnecker R, Dykstra ML, Pierce SK.

Int Rev Immunol. 2001;20(6):805-35. Review.

PMID:
11913951
27.

Life span and synapses: will there be a primary senile dementia?

Terry RD, Katzman R.

Neurobiol Aging. 2001 May-Jun;22(3):347-8; discussion 353-4.

PMID:
11378236
28.

Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway.

Kang DE, Pietrzik CU, Baum L, Chevallier N, Merriam DE, Kounnas MZ, Wagner SL, Troncoso JC, Kawas CH, Katzman R, Koo EH.

J Clin Invest. 2000 Nov;106(9):1159-66.

29.
30.

Relationship between severe amyloid angiopathy, apolipoprotein E genotype, and vascular lesions in Alzheimer's disease.

Olichney JM, Hansen LA, Lee JH, Hofstetter CR, Katzman R, Thal LJ.

Ann N Y Acad Sci. 2000 Apr;903:138-43. Review.

PMID:
10818499
31.

A preliminary analysis of incidence of dementia in Shanghai, China.

Zhang M, Katzman R, Yu E, Liu W, Xiao SF, Yan H.

Psychiatry Clin Neurosci. 1998 Dec;52 Suppl:S291-4.

32.

Great Ape Phenome Project?

Varki A, Wills C, Perlmutter D, Woodruff D, Gage F, Moore J, Semendeferi K, Bernirschke K, Katzman R, Doolittle R, Bullock T.

Science. 1998 Oct 9;282(5387):239-40. No abstract available.

PMID:
9841385
33.

Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.

Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ.

Neurology. 1998 Aug;51(2):351-7.

PMID:
9710002
34.

Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy.

Conrad C, Amano N, Andreadis A, Xia Y, Namekataf K, Oyama F, Ikeda K, Wakabayashi K, Takahashi H, Thal LJ, Katzman R, Shackelford DA, Matsushita M, Masliah E, Sawa A.

Neurosci Lett. 1998 Jul 3;250(2):135-7.

PMID:
9697937
35.

Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer's disease.

Tanaka S, Chen X, Xia Y, Kang DE, Matoh N, Sundsmo M, Thomas RG, Katzman R, Thal LJ, Trojanowski JQ, Saitoh T, Ueda K, Masliah E.

Neurology. 1998 Jun;50(6):1556-62.

PMID:
9633694
36.

Self-perceived health and 5-year mortality risks among the elderly in Shanghai, China.

Yu ES, Kean YM, Slymen DJ, Liu WT, Zhang M, Katzman R.

Am J Epidemiol. 1998 May 1;147(9):880-90.

PMID:
9583719
37.

Risk factors for cardiovascular and cerebrovascular diseases and dementia in the elderly.

Frishman WH, Sokol S, Aronson MK, Wassertheil-Smoller S, Katzman R.

Curr Probl Cardiol. 1998 Jan;23(1):1-62. Review. No abstract available.

PMID:
9494777
39.

Neurobiology of autism.

Rapin I, Katzman R.

Ann Neurol. 1998 Jan;43(1):7-14. Review.

PMID:
9450763
40.

Types of cerebrovascular lesions associated with severe cerebral amyloid angiopathy in Alzheimer's disease.

Olichney JM, Ellis RJ, Katzman R, Sabbagh MN, Hansen L.

Ann N Y Acad Sci. 1997 Sep 26;826:493-7. No abstract available.

PMID:
9329731
41.

The aging brain. Limitations in our knowledge and future approaches.

Katzman R.

Arch Neurol. 1997 Oct;54(10):1201-5. Review. No abstract available.

PMID:
9341564
42.

Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia.

Katzman R, Zhang MY, Chen PJ, Gu N, Jiang S, Saitoh T, Chen X, Klauber M, Thomas RG, Liu WT, Yu ES.

Neurology. 1997 Sep;49(3):779-85.

PMID:
9305340
43.

Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease.

Payami H, Schellenberg GD, Zareparsi S, Kaye J, Sexton GJ, Head MA, Matsuyama SS, Jarvik LF, Miller B, McManus DQ, Bird TD, Katzman R, Heston L, Norman D, Small GW.

Neurology. 1997 Aug;49(2):512-8.

PMID:
9270587
44.

The impact of apolipoprotein E4 on cause of death in Alzheimer's disease.

Olichney JM, Sabbagh MN, Hofstetter CR, Galasko D, Grundman M, Katzman R, Thal LJ.

Neurology. 1997 Jul;49(1):76-81.

PMID:
9222173
45.

Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease.

Kang DE, Saitoh T, Chen X, Xia Y, Masliah E, Hansen LA, Thomas RG, Thal LJ, Katzman R.

Neurology. 1997 Jul;49(1):56-61.

PMID:
9222170
46.

Genetic evidence for the involvement of tau in progressive supranuclear palsy.

Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X, Wiederholt W, Hansen L, Masliah E, Thal LJ, Katzman R, Xia Y, Saitoh T.

Ann Neurol. 1997 Feb;41(2):277-81.

PMID:
9029080
47.

Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism.

Xia Y, Rohan de Silva HA, Rosi BL, Yamaoka LH, Rimmler JB, Pericak-Vance MA, Roses AD, Chen X, Masliah E, DeTeresa R, Iwai A, Sundsmo M, Thomas RG, Hofstetter CR, Gregory E, Hansen LA, Katzman R, Thal LJ, Saitoh T.

Ann Neurol. 1996 Aug;40(2):207-15.

PMID:
8773602
48.

Clinical and neuropathological findings in Lewy body dementias.

Galasko D, Katzman R, Salmon DP, Hansen L.

Brain Cogn. 1996 Jul;31(2):166-75.

PMID:
8811993
49.

Neuropsychological deficits associated with diffuse Lewy body disease.

Salmon DP, Galasko D, Hansen LA, Masliah E, Butters N, Thal LJ, Katzman R.

Brain Cogn. 1996 Jul;31(2):148-65.

PMID:
8811990
50.

The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant.

Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, Thal LJ.

Neurology. 1996 Jul;47(1):190-6.

PMID:
8710076

Supplemental Content

Loading ...
Support Center